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1. Introduction 
Although lithium has remained as the drug of choice in the treatment of bipolar disorder 
over the past 50 years, the mechanism by which it exerts its therapeutic effects is not well 
understood.  A large body of evidence from molecular, cellular and clinical studies proposes  
that lithium have positive actions in enhancing neuroplasticity and synaptic plasticity, and 
these actions are associated with its efficacy  in the treatment of bipolar disorder and other 
psychiatric disorders (Manji et al. 1999; Manji and Duman 2001; Rowe and Chuang 2004; 
Tsaltas et al. 2009).   Lithium modulates intracellular signal transduction pathways involved 
in the activation of transcription factors (PEBP-2β, P53, and CREB) and the gene expression 
of diverse  neurotrophic and neuroprotective factors (Chalecka-Franaszek and Chuang 1999; 
Grimes and Jope 2001; Jope and Roh 2006; Manji et al. 1999; Manji and Duman 2001).  
Among these factors, brain derived neurotrophic factor (BDNF), B-cell CLL/lymphoma 2 
(Bcl-2) and cyclic adenosine monophosphate response element-binding protein (CREB) have 
been the most extensively studied (Angelucci et al. 2003; Chuang et al. 2002; Fukumoto et al. 
2001; Manji and Chen 2002).  It is well known that BDNF, Bcl-2 and CREB play important 
roles in maintaining normal synaptic plasticity in diverse ways (Adams and Cory 1998; 
McAllister et al. 1999; ; Shaywitz and Greenberg 1999; Silva et al. 1998).  Evidence from brain 
imaging and postmortem studies and studies with animal models suggests that in patients 
with bipolar disorder, diverse pathological changes in neuroplastic processes lead to 
impairment in synaptic communications in neuronal circuits involved in the 
pathophysiology of bipolar disorder.  Lithium may enhance synaptic plasticity and thereby 
restore normal synaptic communications in the circuits by up-regulating neurotrophic and 
neuroprotective factor such as BDNF, Bcl-2 and activating CREB, the major transcription 
factor of gene expression of BDNF and Bcl-2, and this action may be associated with the 
efficacy of the drug.  However, this theory has been developed primarily based on 
molecular biological and clinical studies.  This theory has never been fully tested by directly 
examining the effects of lithium exposure on synaptic plasticity.  Only few studies have 
specifically focused on the effects of lithium exposure on synaptic plasticity.  
This study investigated the effects of subchronic and chronic exposure to lithium on synaptic 
plasticity in the hippocampus.  First, the study examined whether 2 weeks and 4 weeks 
lithium treatment alters functional synaptic plasticity by examining the effects of lithium 
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treatment on input and output (I/O) responses and long-term potentiation (LTP) of field 
excitatory postsynaptic potential (fEPSP) of the principal neurons in the dentate gyrus (DG) 
and area CA1 in hippocampal slices.  Second, the study examined the effects of 2 and 4 weeks 
lithium treatment on structural synaptic plasticity by examining effects of lithium treatment on 
the density of dendrites of the principal neurons in DG and area CA1, using the Golgi staining 
and Sholl analysis. The study also examined the effects of the same lithium treatment on the 
levels of phosphorylated CREB (pCREB), Bcl-2 and BDNF, which play critical roles in 
developing and maintaining normal synaptic plasticity, in the DG and area CA1.  
2. Methods 
2.1 Animals and lithium treatment  
Adult male Sprague-Dawley rats weighing 200g to 250g at procurement were housed three 
per cage with food and water available ad libitum and housed in a temperature-controlled 
room with a light/dark cycle of 12/12 hours.  For the 4 weeks lithium study, animals were 
divided as lithium treated group and control groups.  Lithium chows (0.24%  Li2CO3, Harlan 
Teklad®, Madison, WI) or control chow was fed for 4 weeks.  For the 2 weeks lithium study, 
animals were treated and fed the same way as the 4 weeks lithium study.  At the end of 
lithium treatment, the blood levels of lithium were confirmed to be within its therapeutic 
range in human.  Animal treatment and experiments were conducted in accordance with the 
principles and procedures of the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals.   
2.2 Effects of lithium treatment on LTP of the principal neurons in the hippocampus 
Animals were deeply anesthetized with isofluorane inhalation anesthesia.  The brains were 
removed then hemi-sected, the hippocampus was separated from the rest of the hemisphere 
and placed on the stage of a tissue chopper, and 400 micrometer-thick slices were harvested.  
Hippocampal slices for electrophysiological recording were incubated in artificial 
cerebrospinal fluid (aCSF) bubbled with 95%O2/5%CO2 at room temperature until used.  
Hippocampal slices selected for use were placed in an interface-type chamber and perfused 
with oxygenated (95%O2/5%CO2) aCSF and allowed to equilibrate for 30 min.  The aCSF 
was exchanged at a flow rate of 1-1.5ml/min and was composed of (in mM) 125 NaCl, 3.35 
KCl, 1.25 NaH2PO4, 2.0 CaCl2, 2.0 MgSO4, 25 NaHCO3, and 10 glucose. 
For fEPSP recordings in the DG, a bipolar stimulating electrode was placed in the medial 
perforant pathway fibers, and a glass micropipette recording electrode (2-4 M) filled with 
aCSF placed in the granule cell dendritic layer using microelectrode manipulators under an 
illuminated upright microscope.  The same protocol was followed for fEPSP recording in 
hippocampal area CA1.  For LTP recording in hippocampal area CA1, the bipolar 
stimulating electrode was placed in the Schafer collaterals and the recording electrode in the 
apical CA1 dendritic layer for fEPSP. To determine the fEPSP I/O function, stimulations 
(1/20 sec.) at an intensity ranging from just below threshold (~10 uA) until response has 
reached asymptote (no greater than ~900uA) were applied, and responses recorded onto a 
PC utilizing Clampex software.  Five stimulations at each intensity level were given during 
ascending intensities at 10, 30, 50 and 100uA, then increased by 100uA until the maximum 
(900uA ) was reached.   
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Prior to induction of LTP of the fEPSP, a 15 minute baseline was recorded with 
stimulations at 1/20 Hz at a stimulation intensity of 500 uA.  LTP was elicited with 
tetanus of 2 trains of 100Hz stimulations for 0.5sec with a 5 sec interval between trains at 
the same intensity.  LTP was recorded at least for 60 minutes following tetanus with 1/20 
Hz stimulations, and LTP responses only for the last 10 min. (50-60 min) are used for 
analyses to avoid the contamination of noises and other neuronal activities.  All measures 
were made utilizing the same Clampex software used in data collection.  The magnitude 
of all the fEPSPs recorded was expressed by measuring the initial slope of the 
postsynaptic potential waveforms.  For each value, mean  SEM was determined, and the 
resulting values between the lithium treated and control groups were compared 
statistically.  
2.3 Effects of lithium treatment on the density of dendrites in the hippocampus 
2.3.1 Golgi staining 
The Rapid Golgi method was used for this study (Gabbot and Somogyi, 1984).  Animals 
were administered with lithium as described above.  At the end of lithium treatment, the 
chest of animals was opened under deep anesthesia with Nembutal® (75 mg/kg, IP), the 
left ventricle was punctured, and the right atrium incised to allow the blood exit during 
saline injection.  0.9% saline was perfused into the vascular system to flush out the blood 
from the brain.  Then, fixative solution (phosphate buffered 10% formalin) was infused.  
Animals were then decapitated, and the brains were removed.  The blocks of 
hippocampal tissue were separated and fixed in 10% paraformaldeyde and 2.5% 
glutaraldehyde dissolved in 0.1 M phosphate buffer overnight.  The blocks of fixed tissue 
were kept in staining solutions of potassium dichromate and osmium tetraoxide followed 
by immersion in a solution of silver nitrate.  Hippocampal neurons were stained en bloc 
and the stained blocks were then dehydrated in an graded series of increasing ethanol 
concentrations with 1% uranyl acetate and embedded in an ascending series of low 
viscosity nitrocellulose solutions.  The nitrocellulose was hardened by exposure to 
chloroform.  This hardened nitrocellulose was affixed to a sectioning block, and sections 
are cut (at 120 M) on an AO sliding microtome.  The sections were cleared in alpha-
terpineol and mounted on slides under Permount.    
2.3.2 Analysis of dendritic materials (Sholl analysis) 
The slides of Golgi-impregnated neurons were mounted on a Zeiss microscope, which was 
equipped with drawing tubes for preparing camera lucida drawings and digital 
photomicroscopy capabilities.  The analysis defined the amount of dendritic material and its 
spatial distribution.  A template of a series of enlarging concentric circles was centered on 
the soma of each camera lucida drawing of the dendritic trees of neurons.  The number of 
intersections of the dendritic trees with each successive shell was quantified.  This generated 
a profile defining the distribution of the dendritic material at equidistant intervals from the 
soma (every 10 micron increased from the soma).  For each value, mean  SEM was 
determined, and the resulting values between the lithium treated and control groups were 
analyzed statistically. 
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2.4 Effects of lithium treatment on levels of BDNF, Bcl-2 and pCREB in the 
hippocampus 
At the end of the lithium treatment, animals were sacrificed, the brains were hemisected, 
and the hippocampi were separated. Tissues of DA and the areas of CA1 were collected and 
weight. A volume of protein/peptide extraction buffer equal to 4-9 times the tissue weight 
was added. Then, tissue blocks were homogenized with an ultrasonic cell dismemberator 
(Fisher Scientific), boiled for 5 minutes and centrifuged at 15000 for 20 minutes. Thereafter, 
supernatant was transferred to another set of microtubes for further processing immediately 
or stored in -80 °C.  BDNF, pCREB and Bcl-2 levels were determined by the commercially 
available ELISA kits with BDNF from Promega ((Madison, WI) and the kits for p-CREB and 
Bcl-2 from Aldrich-Sigma (St. Louis, MO).  Their protocols of ELISA were followed exactly.  
After completing the entire steps of processing, optical densities of wells microplate were 
read by an assay reader, FLUOstar (BMG LabTech, Germany).  Peptide value of each were 
converted to and presented as the value of pg/mg wet tissue.  The peptide/protein value of 
each was as the value of pg/mg wet tissue or units of activated enzyme/ml.  For each value, 
mean  SEM was determined, and the resulting values between the lithium treated and 
control groups were statistically analyzed.  
3. Results  
This study has obtained results for the effect of lithium treatment for two and four weeks 
lithium on functional (LTP) and structural synaptic plasticity (density of dendrites) and on 
the levels of BDNF, Bcl-2 and pCREB in the DG and hippocampal area CA1 (Table 1).  
 
 
2 Week Lithium Treatment 4 Week Lithium Treatment 
DG Area CA1 DG Area CA1 
Lithium Effects on Synaptic Plasticity 
LTP  - *  
I/O  - -  
Lithium Effects on Density of Dendrites and Dendritic Spines 
Dendrites     
Lithium Effects on Levels of BDNF, Bcl-2 and P-CREB 
BDNF     
Bcl-2     
p-CREB     
Table 1. Effects of 2 weeks and 4 weeks lithium treatments on functional and structural 
synaptic plasticity and the levels of BDNF, Bcl-2 and pCREB in the hippocampus. Shim and 
Russell 2004; Hammonds et al. 2007; Hammonds and Shim 2009; Shim et al. 2007; Shim and 
Hammonds 2009; Shim and Hammonds 2010; *Son et al. 2003 
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3.1 Effects of lithium treatment on LTP of the principal neurons in the hippocampus  
Four weeks lithium treatment did not enhance the magnitude of I/O responses (Fig. 2), but 
significantly enhanced the magnitude of LTP of fEPSP of CA1 pyramidal cells (Figs. 1, 3).  
Two weeks lithium treatment significantly enhanced the magnitude of I/O responses and 
LTP of fEPSP of the DG granule cells (Figs. 4, 5). (Shim and Hammonds 2009; Shim et al. 
2007). 
 
Fig. 1. Typical wave forms of LTP  of fEPSP of the granule cells in DG. 
 
Fig. 2. Effects of 4 weeks lithium treatment on I/O responses of fEPSP in area CA1.  There 
was no significant differences in I/O response between lithium (number of animals (N) =19; 
number of slices (n) = 34) and control (N =16, n = 30) chow treatment [p > 0.05, independent 
Student’s t-tests 
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Fig. 3. Effects of 4 weeks lithium treatment on LTP of fEPSP in area CA1.  Two trains of 100 
Hz tetanus stimuli significantly magnified fEPSP of CA1 pyramidal cells as determined for 
the last 10 min. of the recordings.  There was significant differences in LTP responses 




Fig. 4. Effects of 2 weeks lithium treatment on I/O responses of fEPSP in the DG.  There was 
significant differences in I/O response between lithium (N = 5; n = 6) and control (N = 4, n = 
5) chow treatment [(p  0.01, independent Student's t-test).  
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Fig. 5. Effects of 2 weeks lithium treatment on LTP of fEPSP in the DG.  Two trains of 100 Hz 
tetanus stimuli significantly magnified fEPSP of the DG granule cells as determined for the 
last 10 min. of the recordings.  There was significant differences in LTP responses between 
lithium treated (N = 4, n = 5) and control (N = 5, n = 6) animals in the DG [p < 0.01, 
independent Student's t-test]. 
3.2 Effects of lithium treatment on density of dendrites in the hippocampus   
Sholl analysis shows that 4 weeks and 2 weeks lithium treatments redistributed dendritic 
branches in different manners.  In the DG granule cells, 4 weeks lithium treatment increased 
the number of dendritic branches in nearly the inner 2/3 of dendritic trees, but reduced the 
number of the branches in outer 1/3 of dendritic trees (Figs. 6, 7).  In hippocampal area CA1, 
the same lithium treatment increased the number of apical dendritic branches in the inner  
2/3 of the dendritic trees, whereas, in the distal 1/3 of the apical tree, the treatment reduced 
dendritic branching (Fig. 8).  In contrast, 2 weeks lithium treatment reduced the number of 
dendritic branches approximately in the outer 2/3 of the dendritic trees of the DG granule 
cells (Fig. 9).  The same treatment reduced the apical dendritic branches of CA1 pyramidal 
cells throughout dendritic trees except a small proximal region of the dendrites (Fig. 10).  
Both 4 and 2 weeks lithium treatments redistributed dendritic branches without significant 
changes in the total number of them in the DG and area CA1 (Shim and Hammonds 2010; 
Shim and Russell 2004).   
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Fig. 6. (A) Golgi impregnated granule cells with well branched and bifurcated dendrites 
extending into the molecular layers in the DG.  (B) Camera lucida drawing of the dendritic 
trees of hippocampal CA1 pyramidal cells.  The dendritic branches of a CA1 pyramidal cell 
under a concentric shell template for Sholl dendrite density analysis are shown. 
 
Fig. 7.  Effects of 4 weeks lithium treatment on dendrites of the DG granule cells.  Lithium-
treated animals (lithium-treated animals N = 6, n = 30; controls N = 4, n = 16) have 
significantly more dendritic branches in the inner 2/3 of dendritic trees (Wilcoxonn test, p = 
0.0038).  In the outer 1/3 of dendrtic trees, lithium-treated animals have less dendritic 
branches (Wilsoxon test, p = 0.0024) broken line: lithium treated group; full line: control 
group. The over-all dendritic material of granule cells is not significantly different between 
the two groups.  
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Fig. 8. Effects of 4 weeks lithium treatment on apical dendrites of the CA1 pyramidal cells.  
Lithium-treated animals (lithium-treated animals N = 3, n = 8; controls N=4, n=10) have 
significantly more dendritic branches in the inner 2/3 of dendritic branches (Wilcoxonn test, 
p = 0.0005).  In the outer 1/3 of dendrtic trees, lithium-treated animals have less dendritic 
branches of dendrites  (Wilcoxon test, p < 0.0009). The total amount of dendritic material of 
CA1 pyramidal cells is not significantly different between the two groups. 
 
Fig. 9. Effects of 2 weeks lithium treatment on dendritic branches of the DG granule cells.  
The lithium treated animals (N = 3; n = 18) had significantly less dendritic branches on the 
outer 2/3 of dendritic tree comparing to those in the control group (N = 3, n = 18) (p = 0.001, 
Wilcoxon test).  The over-all dendritic branches of granule cells were not statistically 
significant between the two groups.  
www.intechopen.com

















Fig. 10. Effects of 2 weeks lithium treatment on apical dendritic branches of area CA1 
pyramidal neurons.  The loss of dendritic branches was found in more than the outer 2/3 of 
the dendritic arbor in the lithium treated group (p< 0.0001, Wilcoxon test)(lithium –treated 
group N =3, n=18; Controls N = 3, n=17).  The total amount of dendritic branches was not 
significantly different between the two groups.  
3.3 Effects of lithium treatment on levels of BDNF, Bcl-2 and pCREB in the 
hippocampus 
This study have also examined the effects of 4 weeks and 2 weeks lithium treatments on the 
levels of BDNF, Bcl-2 and p-CREB in the DG and area CA1 using ELISA.  Four weeks 
lithium treatment increased the levels of Bcl-2 and pCREB in the DG and area CA1 (Fig 11B, 
11C) (Hammonds and Shim 2009).  This treatment increased the level of BDNF in the DG, 
but did not increase the level of BDNF, in area CA1 (Fig. 11A).  However, 2 weeks lithium 
treatment did not alter the levels of BDNF, Bcl-2 and pCREB in either the DG or area CA1 
(Figures are not shown) (Hammmonds and Shim 2007). 
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Fig. 11. Effects of 4-weeks lithium treatment on levels of BDNF, Bcl-2 and pCREB in the DG 
and area CA1.  (A) There was significant difference in the levels of BDNF between the two 
groups (N = 6 of each group) in DG (p = 0.016, independent Student t-test), but no 
significant difference between the two groups in area CA1 (p = 0.227). There was significant 
difference in the level of total free Bcl-2 (p< 0.001 in DG; p< 0.025 in CA1) (B) and pCREB (p 
= 0.001 in DG; p< 0.001 in CA1) (C) between the lithium-treated (N = 6) control groups (N = 
6) in both areas Two weeks lithium treatment did not change the levels of BDNF, Bcl-2 and 
pCREB in the DG and area CA1 (Hammonds et al, 2007.. 
4. Discussion 
Our study found that chronic lithium treatment (CLT) magnified the expression of LTP of 
hippocampal area CA1 pyramidal cells (Fig. 3) without enhancing baseline synaptic response 
(Fig. 2), and subchronic lithium treatment (SCLT) magnified LTP and I/O function of the DG 
granule cells (Figs. 4, 5).  Son et al. (2003) also reported that 4 weeks lithium treatment 
magnified LTP in the DG.  Previously, we reported that 2 weeks lithium treatment magnified 
LTP in the DG (Shim et al. 2007).  Our findings combined with others suggest that long-term 
lithium treatment increases synaptic plasticity in the hippocampus.  We recently observed that 
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acute in vitro and in vivo (one day) lithium treatment decreased the magnitude of LTP in area 
CA1 (a manuscript in preparation).  These findings together supports our hypothesis that 
prolonged lithium  treatment upregulates functional synaptic plasticity in the hippocampus, 
and this effect may not be associated with the direct chemical effect of lithium, but is likely to 
be associated with the molecular actions of lithium at genetic levels.  Since hippocampal 
synaptic plasticity is known to underlie memory and learning, we investigated the effects of 
CLT on learning and memory (Nocjar et al 2007), which showed CLT increases learning and 
memory. This suggests the possibility that lithium can have therapeutic effects in patients with 
Alzheimer's disease and other dementia. (Engel et al. 2008).  
Our sholl analyses of the effects of lithium treatment on dendrites suggest that prolonged 
lithium treatment produces a remodeling in the distribution of dendrites of the principal 
neurons in the hippocampus. Interestingly, CLT and SCLT remodels in distribution of 
dendrites in different manners. CLT produces an increase in the distribution of dendritic 
branches with more branches in the segment of highly populated branches of dendritic 
trees and reduces dendritic branches in the segment of less populated branches (Figs. 7, 
8). The consequence of this redistribution is unknown.  We hypothesize that CLT 
produces more branches in the segment of denritic trees, where synapses with major 
excitatory input occurs form, and the most active synaptic transmission occurs, whereas 
CLT reduces branches in the segment where less synapses form.  This structural 
remodeling  may lead to  an enhancement in synaptic transmission in a more efficient 
manner.  SCLT remodels in distribution of dendritic branches in a manner opposite to the 
manner CLT does.  SCLT decreases dendritic branches in dendrite segments, where 
branches are highly distributed and active synaptic interactions occur (Fig. 9, 10).   This 
unexpected finding is not due to lithium toxicity.  In our studies,  lithium was  
administered twice daily (1 mEq/kg a day) for the two weeks lithium study, and no 
animals died or showed signs of lithium toxicity.  It was confirmed that the blood levels of 
lithium were within the human therapeutic range of 0.51 to 0.78 mEq/L (Baldessarini and 
Tarazi, 2001).  Furthermore, In our 4 weeks lithium treatment studies, animals were fed 
lithium chow for 4 weeks, and their lithium blood levels were again confirmed to be 
within the therapeutic range (0.68 to 0.89 mEq/L).  Thus, lithium toxicity is not supported 
as a potential cause for the findings in the current studies.  The dendritic segments where 
SCLT reduces dendritic branching are the region where dendrites receive major excitatory 
input and form main synapses with the input.  Our study shows that SCLT increase 
baseline synaptic transmission and LTP, which was recorded approximately in the same 
region of the DG as the region where SCLT reduced dendritic branches (Figs. 4, 5).  It is 
possible that the lithium-induced loss of dendritic branches in these regions could 
dampen excited synaptic activity as a homeostatic adaptive response to maintain 
physiologically efficacious synaptic transmission.   
Our results show that CLT upregulates Bcl-2 and CREB in the DG and hippocampal area 
CA1 and upregulates BDNF in the DG (Fig. 11).  However, SCLT does not upregulate 
BDNF, Bcl-2 or CREB in these hippocampal subregions (Hammonds et al. 2007).  These 
findings suggest that CLT, not SCLT, upregulates these neuroplatic proteins, which are 
actively involved in synaptic plasticity.  
Our results from electrophysiological, morphological and molecular studies suggest that 
SCLT may increase functional synaptic plasticity.  SCLT, however, increases neither the 
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density of dendrites in the active synaptic regions of dendritic trees of the principal neurons 
nor the levels of BDNF, Bcl-2 and pCREB in the hippocampus.  In contrast, CLT increases 
functional synaptic strength, which is accompanied with remodels in distribution of 
dendritic branches in such a way that  more dendritic material is available in dendritic 
regions where the most active synaptic activity occurs.  These cellular changes are consistent 
with the up-regulation of BDNF, Bcl-2 and pCREB in the hippocampus.  Thus, CLT may 
produce more stable and persistent changes in synaptic plasticity in the hippocampus.  In 
contrast, SCLT may increase the functional  aspect of synaptic plasticity.  These changes may 
not be accompanied with the increased density of dendrites at active synaptic regions or the 
up-regulation of neuroplastic proteins.  These findings are consistent with the clinical 
observation that lithium takes 3-4 weeks to show its efficacy in treatment of bipolar disorder 
and other mental illness (Baldessarinni and Tarazi 2001).  
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